2017 Q3 Form 10-Q Financial Statement
#000114420417058350 Filed on November 13, 2017
Income Statement
Concept | 2017 Q3 | 2016 Q4 | 2016 Q3 |
---|---|---|---|
Revenue | $1.863M | $1.820M | $1.160M |
YoY Change | 60.64% | 106.82% | 42.83% |
Cost Of Revenue | $560.0K | $520.0K | $380.0K |
YoY Change | 47.37% | 188.89% | 49.07% |
Gross Profit | $1.300M | $1.300M | $780.0K |
YoY Change | 66.67% | 85.71% | 40.05% |
Gross Profit Margin | 69.79% | 71.43% | 67.27% |
Selling, General & Admin | $888.1K | $1.090M | $882.2K |
YoY Change | 0.67% | 15.96% | 4.86% |
% of Gross Profit | 68.32% | 83.85% | 113.1% |
Research & Development | $8.654K | ||
YoY Change | 69.42% | ||
% of Gross Profit | 1.11% | ||
Depreciation & Amortization | $10.00K | $0.00 | $10.00K |
YoY Change | 0.0% | 0.0% | |
% of Gross Profit | 0.77% | 0.0% | 1.28% |
Operating Expenses | $888.1K | $1.090M | $890.9K |
YoY Change | -0.31% | 17.2% | 5.25% |
Operating Profit | $409.9K | $210.0K | -$101.5K |
YoY Change | -503.87% | -191.3% | -64.31% |
Interest Expense | $20.00K | $20.00K | $30.00K |
YoY Change | -33.33% | -33.33% | |
% of Operating Profit | 4.88% | 9.52% | |
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $430.0K | $230.0K | -$80.00K |
YoY Change | -637.5% | -200.0% | -69.73% |
Income Tax | $160.0K | $90.00K | $0.00 |
% Of Pretax Income | 37.21% | 39.13% | |
Net Earnings | $272.0K | $140.0K | -$74.61K |
YoY Change | -464.61% | -216.67% | -56.11% |
Net Earnings / Revenue | 14.61% | 7.69% | -6.43% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $59.87K | $31.04K | -$15.52K |
COMMON SHARES | |||
Basic Shares Outstanding | 4.504M shares | 4.510M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q3 | 2016 Q4 | 2016 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $540.0K | $100.0K | $180.0K |
YoY Change | 200.0% | -65.52% | -48.57% |
Cash & Equivalents | |||
Short-Term Investments | |||
Other Short-Term Assets | $90.00K | $150.0K | $160.0K |
YoY Change | -43.75% | 66.67% | 166.67% |
Inventory | $490.0K | $843.2K | $680.0K |
Prepaid Expenses | $151.1K | ||
Receivables | $3.790M | $2.807M | $2.730M |
Other Receivables | $10.00K | $170.0K | $210.0K |
Total Short-Term Assets | $4.930M | $4.080M | $3.970M |
YoY Change | 24.18% | 13.45% | 0.91% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $80.00K | $33.43K | $40.00K |
YoY Change | 100.0% | -38.71% | -28.98% |
Goodwill | |||
YoY Change | |||
Intangibles | $273.00 | ||
YoY Change | -83.33% | ||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $1.292M | $180.0K |
YoY Change | -100.0% | 0.13% | -80.05% |
Total Long-Term Assets | $2.710M | $2.901M | $4.170M |
YoY Change | -35.01% | -10.65% | 40.03% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.930M | $4.080M | $3.970M |
Total Long-Term Assets | $2.710M | $2.901M | $4.170M |
Total Assets | $7.640M | $6.981M | $8.140M |
YoY Change | -6.14% | 2.02% | 17.76% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $240.0K | $470.0K | $550.0K |
YoY Change | -56.36% | 14.63% | 30.95% |
Accrued Expenses | $100.0K | $30.00K | $20.00K |
YoY Change | 400.0% | 0.0% | -75.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $20.00K | $10.00K | $10.00K |
YoY Change | 100.0% | 0.0% | 0.0% |
Total Short-Term Liabilities | $390.0K | $1.450M | $1.450M |
YoY Change | -73.1% | 12.88% | 9.76% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $30.00K | $20.00K | $20.00K |
YoY Change | 50.0% | -33.33% | -33.33% |
Other Long-Term Liabilities | $3.190M | $2.750M | $4.050M |
YoY Change | -21.23% | -4.84% | 45.16% |
Total Long-Term Liabilities | $3.220M | $2.770M | $4.070M |
YoY Change | -20.88% | -5.14% | 44.69% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $390.0K | $1.450M | $1.450M |
Total Long-Term Liabilities | $3.220M | $2.770M | $4.070M |
Total Liabilities | $4.570M | $4.220M | $5.530M |
YoY Change | -17.36% | 0.45% | 33.77% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | |||
YoY Change | |||
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $146.4K | $146.4K | |
YoY Change | 18.47% | ||
Treasury Stock Shares | 144.8K shares | 144.8K shares | 152.3K shares |
Shareholders Equity | $3.080M | $2.760M | $2.620M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $7.640M | $6.980M | $8.140M |
YoY Change | -6.14% | 2.01% | 17.76% |
Cashflow Statement
Concept | 2017 Q3 | 2016 Q4 | 2016 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $272.0K | $140.0K | -$74.61K |
YoY Change | -464.61% | -216.67% | -56.11% |
Depreciation, Depletion And Amortization | $10.00K | $0.00 | $10.00K |
YoY Change | 0.0% | 0.0% | |
Cash From Operating Activities | $320.0K | -$80.00K | $170.0K |
YoY Change | 88.24% | 100.0% | -185.0% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$30.00K | $0.00 | $0.00 |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | ||
YoY Change | |||
Cash From Investing Activities | -$30.00K | $0.00 | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -10.00K | 0.000 | -20.00K |
YoY Change | -50.0% | -100.0% | -66.67% |
NET CHANGE | |||
Cash From Operating Activities | 320.0K | -80.00K | 170.0K |
Cash From Investing Activities | -30.00K | 0.000 | 0.000 |
Cash From Financing Activities | -10.00K | 0.000 | -20.00K |
Net Change In Cash | 280.0K | -80.00K | 150.0K |
YoY Change | 86.67% | 60.0% | -157.69% |
FREE CASH FLOW | |||
Cash From Operating Activities | $320.0K | -$80.00K | $170.0K |
Capital Expenditures | -$30.00K | $0.00 | $0.00 |
Free Cash Flow | $350.0K | -$80.00K | $170.0K |
YoY Change | 105.88% | 100.0% | -185.0% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016Q3 | us-gaap |
Revenues
Revenues
|
1159530 | USD |
us-gaap |
Gross Profit
GrossProfit
|
3507453 | USD | |
us-gaap |
Gross Profit
GrossProfit
|
2883386 | USD | |
CY2017Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
888105 | USD |
CY2016Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
882201 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3080953 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2886408 | USD | |
CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
409926 | USD |
CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-101500 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
426500 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-7644 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-20035 | USD | |
CY2017Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
24718 | USD |
CY2016Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
29324 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
83310 | USD | |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
272049 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-74613 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
312666 | USD | |
CY2017Q3 | us-gaap |
Revenues
Revenues
|
1862684 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3685 | USD | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.07 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0 | ||
CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4511965 | shares |
CY2016Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4507182 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4511965 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
4518103 | shares | |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
914000 | USD |
CY2016Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
146360 | USD |
CY2017Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
146360 | USD |
CY2016Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
7096 | USD |
CY2017Q3 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
19119 | USD |
CY2017Q3 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
954000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
0 | USD |
us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
38875 | USD | |
us-gaap |
Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-37375 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD | |
us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
32435 | USD | |
CY2017Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
CY2016Q3 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
1500 | USD | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
16854 | USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
21995 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
202000 | USD | |
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
194000 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1081830 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1284134 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
25648 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-350035 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
318149 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-314939 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
139268 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-229888 | USD | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-7577 | USD | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
73976 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1147077 | USD | |
us-gaap |
Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
|
-146332 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-64277 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
483495 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
5412 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-41768 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-7737 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-106045 | USD | |
CY2015Q4 | us-gaap |
Cash
Cash
|
289105 | USD |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
6375 | USD | |
us-gaap |
Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
|
0 | USD | |
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
1500 | USD | |
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | USD | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
131454 | USD | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | USD | |
us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
1500 | USD | |
us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | USD | |
CY2016Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8654 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
36157 | USD | |
CY2016Q4 | tbtc |
Accounts Receivable Under Normal30 Days
AccountsReceivableUnderNormal30Days
|
979564 | USD |
CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4656734 | shares |
CY2017Q3 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
144769 | shares |
CY2017Q3 | tbtc |
Accounts Receivable Under Normal30 Days
AccountsReceivableUnderNormal30Days
|
2229362 | USD |
CY2017Q3 | us-gaap |
Other Commitment
OtherCommitment
|
19000 | USD |
CY2017Q3 | us-gaap |
Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
|
3223451 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
|
2910785 | USD |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4511965 | shares |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> </div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <u><font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt"> <font style="FONT-FAMILY: 'Times New Roman',serif; FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company uses estimates and assumptions in accounting for the following significant matters, among others: revenue recognition, realizability of accounts receivable, the valuation of deferred tax assets and liabilities, deferred revenue and costs, and the valuation of inventory. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
CY2016Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
141238 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
30793 | USD | |
CY2017Q2 | tbtc |
Additional Allowance For Doubtful Debts
AdditionalAllowanceForDoubtfulDebts
|
150000 | USD |